Biomarin Pharmaceutical Inc. (BMRN)
NASDAQ · Healthcare
Biomarin Pharmaceutical Inc. Income Statement 2008–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||||
| Revenue | 3.22B | 2.85B | 2.42B | 2.10B | 1.85B | 1.86B | 1.70B | 1.49B | 1.31B | 1.12B | 889.9M | 749.3M | 548.5M | 500.7M | 441.4M | 376.3M | 324.7M | 296.5M |
| Gross Profit | 2.50B | 2.27B | 1.89B | 1.59B | 1.38B | 1.34B | 1.34B | 1.18B | 1.07B | 907.2M | 737.9M | 627.0M | 460.1M | 408.9M | 357.3M | 306.0M | 258.7M | 244.0M |
| Profitability | ||||||||||||||||||
| Operating Income | 409.5M | 484.2M | 185.8M | 161.0M | -82.3M | -43.4M | -100.5M | -123.5M | -14.7M | -803.4M | -110.7M | -92.9M | -156.0M | -110.2M | -33.9M | 544,000 | 16.4M | 39.8M |
| EBITDA | 489.0M | 580.6M | 290.2M | 262.9M | 25.7M | 61.7M | 4.8M | -27.9M | 73.2M | -706.5M | -63.5M | -47.0M | -120.0M | -65.9M | 1.2M | 28.3M | 37.4M | 57.4M |
| Net Income | 348.9M | 426.9M | 167.6M | 141.6M | -64.1M | 854.0M | -23.8M | -77.2M | -117.0M | -630.2M | -171.8M | -134.0M | -176.4M | -114.3M | -53.8M | 205.8M | -488,000 | 30.8M |
| Per Share Data | ||||||||||||||||||
| EPS (diluted) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 197M | 197M | 192M | 189M | 183M | 192M | 179M | 177M | 174M | 166M | 160M | 146M | 143M | 120M | 112M | 126M | 100M | 104M |
Biomarin Pharmaceutical Inc. Income Statement — FAQ
Biomarin Pharmaceutical Inc. (BMRN) income statement over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BMRN's income statement history?
The chart and table above show Biomarin Pharmaceutical Inc.'s income statement by year and by quarter, including the growth rate.